
Debiopharm and Oncodesign Services Collaborate to Advance Radiopharmaceuticals in Preclinical Research
Debiopharm Research & Manufacturing and Oncodesign Services announced the execution of a license agreement for the use of the AbYlink™ technology for preclinical services. AbYlink™ is a regio-selective bioconjugation technology ideally suited for …